XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE (Details) - $ / shares
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Grant date closing price of Common Stock   $ 25.25 $ 130.75
Expected term (years)   3 years 6 months 3 years 6 months
Risk-free interest rate   3.40% 0.80%
Volatility   112.00% 141.00%
Dividend yield   0.00% 0.00%
Warrant [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Grant date closing price of Common Stock $ 18.25 [1] $ 19.75 [2] $ 186.00 [2]
Expected term (years) 5 years [3] 5 years [4] 2 years 7 months 6 days [4]
Risk-free interest rate 4.20% 3.60% 0.30%
Volatility 102.00% 102.00% 138.00%
Dividend yield 0.00% 0.00% 0.00%
Share-Based Payment Arrangement, Option [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Grant date closing price of Common Stock $ 10.00    
Expected term (years) [5] 3 years 6 months    
Risk-free interest rate 3.90%    
Volatility 102.00%    
Dividend yield 0.00%    
[1] Weighted average grant price.
[2] Weighted average grant price.
[3] The valuation of warrants is based on the expected term.
[4] The valuation of warrants is based on the contractual term of the warrant rather than the expected term.
[5] Represents the weighted average remaining contractual term until the warrants expire.